Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

10161	Companies
208732	Keywords
138857	Articles
110647	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 1 year 11 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 1 year 11 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 1 year 11 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 1 year 11 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 2 years ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 2 years ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 2 years ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 2 years ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 2 years ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 2 years ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 04/02/2026 at 22:00, 1 day 12 hours ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 15 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 19 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 19 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 19 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 10:07, 3 minutes ago

Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 8 hours 5 minutes ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 16 hours 10 minutes ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 16 hours 10 minutes ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 16 hours 25 minutes ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems

Les Echos

Published on 04/03/2026 at 18:46, 15 hours 23 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 15 hours 23 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 16 hours 8 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 16 hours 10 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 16 hours 10 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE